According to WiseGuy Reports, the Dextranase Enzyme Market was valued at USD 200 million in 2024 and remained at USD 200 million in 2025. The market is projected to reach USD 300 million by 2035, registering a CAGR of 2.6% from 2026 to 2035. Increasing diabetes prevalence, growing biopharmaceutical applications, rising demand for disease control, greater awareness of enzyme-based solutions, and advancements in biotechnology are supporting market development. Key companies profiled include Hongya Qiao, Genomatica, Shandong Longda, Jiangsu Boli Bioproducts, Kokusan Chemical, Wacker Chemie, DuPont, DSM, Novozymes, SABIC, Fujifilm, Zhejiang New Respect, BASF, Amano Enzyme, and Biocatalysts.

Market Overview

Dextranase is an enzyme that breaks down dextran, a complex polysaccharide formed by microorganisms from sucrose. Its ability to degrade dextran makes it valuable across food processing, healthcare, biotechnology, agriculture, and other industrial applications. Growing interest in enzymatic processing is creating opportunities for manufacturers and technology providers developing specialized dextranase solutions.

The market is segmented by application, source, form, end-use industry, and region. Major applications include food and beverages, pharmaceuticals, biotechnology, and animal feed. Dextranase products are derived from microbial, plant, and animal sources and are supplied in liquid, powder, and granular forms to meet different processing requirements.

Food processing remains an important application area because dextran accumulation can affect processing efficiency and product quality. Pharmaceutical and biotechnology applications are also contributing to demand as enzyme-based processes gain greater relevance in specialized research and manufacturing activities.

Market Size and Growth Outlook

The Dextranase Enzyme Market was valued at USD 200 million in 2024 and USD 200 million in 2025. The market is forecast to reach USD 300 million by 2035, reflecting a CAGR of 2.6% during the 2026–2035 forecast period.

The gradual expansion of the market is supported by increasing demand for enzymes in food processing and the continued development of pharmaceutical and biotechnology applications. Rising awareness of enzyme-based processing solutions is encouraging industries to evaluate alternatives that can improve process efficiency and support targeted applications.

The expansion of animal feed applications is another factor contributing to market opportunities. Enzymes are increasingly incorporated into specialized feed formulations and processing systems, creating additional demand for enzyme manufacturers.

Key Growth Drivers

The increasing demand for enzyme applications in the food industry is a major growth driver. Dextran can create processing challenges in certain food and beverage manufacturing environments, making dextranase useful for controlling unwanted polysaccharide accumulation and improving processing conditions.

Growing pharmaceutical and biotechnology applications are also supporting market development. Enzymes are used in various biotechnological processes, research activities, and specialized pharmaceutical applications. Continued advances in biotechnology can expand the range of applications for dextranase products.

Increasing diabetes prevalence is another market dynamic identified in the market outlook. Greater attention to disease management and healthcare-related research can support demand for specialized biochemical and enzymatic solutions.

Advancements in biotechnology are further improving enzyme development, production, and application. Improvements in microbial fermentation, enzyme formulation, and process optimization can contribute to the availability of more effective and application-specific dextranase products.

Emerging Market Trends

The development of microbial sources is an important trend in the dextranase enzyme industry. Microbial production can support scalable enzyme manufacturing and enable producers to develop formulations suited to specific industrial requirements.

Product formulation is also becoming increasingly important. Liquid, powder, and granular forms provide manufacturers and end users with different handling, storage, and application options. Selection of the appropriate form depends on processing conditions, dosage requirements, and end-use applications.

The food processing industry continues to offer significant opportunities as manufacturers seek enzyme-based solutions for improving production efficiency. Pharmaceutical and biotechnology applications are also expanding the potential use of dextranase beyond traditional food-related applications.

Asia Pacific is emerging as an important regional opportunity due to increasing industrial activity, expanding food processing capabilities, growing pharmaceutical production, and continued development of biotechnology. The region's expanding manufacturing base can support demand for specialized enzymes.

Expected Market Size by 2035

The Dextranase Enzyme Market is expected to reach USD 300 million by 2035. North America, Europe, South America, Asia Pacific, and the Middle East and Africa are included in the regional assessment.

North America is supported by established food processing, pharmaceutical, biotechnology, and research industries. Demand for specialized enzyme technologies across these sectors can provide a stable foundation for market development.

Europe also represents an important market because of its developed food and beverage industry, pharmaceutical capabilities, and focus on advanced biotechnology. Industrial interest in efficient and targeted enzymatic processes can support adoption.

Asia Pacific is expected to provide emerging growth opportunities, particularly across China, India, Japan, South Korea, Malaysia, Thailand, and Indonesia. Expansion of food processing, healthcare, agriculture, and biotechnology activities can increase the application base for dextranase enzymes.

South America and the Middle East and Africa are also covered in the regional market analysis. Growth in food processing and agriculture, together with increasing awareness of enzyme technologies, can create additional opportunities for manufacturers.

Market CAGR

The market is projected to register a CAGR of 2.6% from 2026 to 2035. This moderate growth rate reflects the expanding application base for dextranase across food processing, healthcare, biotechnology, agriculture, and cosmetics.

Increasing demand from the food industry, expansion of pharmaceutical and biotechnology applications, and growing use of enzymes in animal feed are expected to support steady market development. Advances in enzymatic technologies can further improve product functionality and expand the range of commercial applications.

Competitive Landscape

The competitive landscape includes enzyme manufacturers, biotechnology companies, chemical producers, and specialized technology providers. Hongya Qiao, Genomatica, Shandong Longda, Jiangsu Boli Bioproducts, Kokusan Chemical, Wacker Chemie, DuPont, DSM, Novozymes, SABIC, Fujifilm, Zhejiang New Respect, BASF, Amano Enzyme, and Biocatalysts are among the key companies profiled.

Competition is shaped by enzyme quality, production capabilities, formulation technology, research and development, application expertise, and distribution reach. Companies are focusing on improving enzyme performance and developing solutions suited to the requirements of food processing, pharmaceutical, biotechnology, agriculture, and other end-use industries.

Continued biotechnology advancements, rising industrial adoption of enzyme-based solutions, and increasing demand for specialized processing technologies are expected to create sustained opportunities for participants in the Dextranase Enzyme Market through 2035.